StockData

VitaNova Life Sciences Corp (VNOV) stock

VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$4.50+0.50 (+12.50%)

Close on Oct 19, 2026Market cap $37.52MP/E –Yield –

VitaNova Life Sciences operating margin

Operating margin is operating income as a percentage of revenue.

VitaNova Life Sciences's operating margin for the twelve months ending Jul 31, 2026 was -2.7%. For fiscal 2026 it was 0.1%, against 45.4% the year before. The highest annual figure on record is 45.4% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2026Apr 30, 20260.1%−45.3
FY2025Apr 30, 202545.4%+9.4
FY2024Apr 30, 202436.0%+99.8
FY2023Apr 30, 2023-63.8%−52.6
FY2022Apr 30, 2022-11.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ2 2026Jul 31, 2026-38.0%−6.8
Q4 FY2026CQ1 2026Apr 30, 2026-6.2%−61.6
Q3 FY2026CQ4 2025Jan 31, 20266.6%−28.7
Q2 FY2026CQ3 2025Oct 31, 202523.2%+1.8
Q1 FY2026CQ2 2025Jul 31, 2025-31.2%+10.6
Q4 FY2025CQ1 2025Apr 30, 202555.4%+12.7
Q3 FY2025CQ4 2024Jan 31, 202535.3%+12.5
Q2 FY2025CQ3 2024Oct 31, 202421.4%+7.2
Q1 FY2025CQ2 2024Jul 31, 2024-41.9%+24.8
Q4 FY2024CQ1 2024Apr 30, 202442.7%–
Q3 FY2024CQ4 2023Jan 31, 202422.8%–
Q1 FY2023CQ2 2022Jul 31, 202214.2%–
Q2 FY2022CQ3 2021Oct 31, 2021-66.6%–

More VitaNova Life Sciences figures

See a number that looks wrong?